Global and Japan Anti-inflammatory Biologics Market Insights, Forecast to 2027
SKU ID : QYR-19049531 | Publishing Date : 01-Sep-2021
Detailed TOC of Global and Japan Anti-inflammatory Biologics Market Insights, Forecast to 2027
1 Study Coverage1.1 Anti-inflammatory Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Type
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Market by Application
1.3.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Application
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-inflammatory Biologics Market Size, Estimates and Forecasts
2.1.1 Global Anti-inflammatory Biologics Revenue 2016-2027
2.1.2 Global Anti-inflammatory Biologics Sales 2016-2027
2.2 Global Anti-inflammatory Biologics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anti-inflammatory Biologics Historical Market Size by Region (2016-2021)
2.3.1 Global Anti-inflammatory Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anti-inflammatory Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anti-inflammatory Biologics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027)
2.4.2 Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027)
3 Global Anti-inflammatory Biologics Competitor Landscape by Players
3.1 Global Top Anti-inflammatory Biologics Manufacturers by Sales
3.1.1 Global Anti-inflammatory Biologics Sales by Manufacturer (2016-2021)
3.1.2 Global Anti-inflammatory Biologics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anti-inflammatory Biologics Manufacturers by Revenue
3.2.1 Key Anti-inflammatory Biologics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anti-inflammatory Biologics Revenue by Manufacturers (2016-2021)
3.2.3 Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anti-inflammatory Biologics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anti-inflammatory Biologics Revenue in 2020
3.2.6 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-inflammatory Biologics Price by Manufacturers
3.4 Global Anti-inflammatory Biologics Manufacturing Base Distribution, Product Types
3.4.1 Anti-inflammatory Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-inflammatory Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Anti-inflammatory Biologics Market Size by Type (2016-2021)
4.1.1 Global Anti-inflammatory Biologics Sales by Type (2016-2021)
4.1.2 Global Anti-inflammatory Biologics Revenue by Type (2016-2021)
4.1.3 Anti-inflammatory Biologics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anti-inflammatory Biologics Market Size Forecast by Type (2022-2027)
4.2.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027)
4.2.3 Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Anti-inflammatory Biologics Market Size by Application (2016-2021)
5.1.1 Global Anti-inflammatory Biologics Sales by Application (2016-2021)
5.1.2 Global Anti-inflammatory Biologics Revenue by Application (2016-2021)
5.1.3 Anti-inflammatory Biologics Price by Application (2016-2021)
5.2 Anti-inflammatory Biologics Market Size Forecast by Application (2022-2027)
5.2.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-inflammatory Biologics Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
6.1.1 Japan Anti-inflammatory Biologics Sales YoY Growth 2016-2027
6.1.2 Japan Anti-inflammatory Biologics Revenue YoY Growth 2016-2027
6.1.3 Japan Anti-inflammatory Biologics Market Share in Global Market 2016-2027
6.2 Japan Anti-inflammatory Biologics Market Size by Players (International and Local Players)
6.2.1 Japan Top Anti-inflammatory Biologics Players by Sales (2016-2021)
6.2.2 Japan Top Anti-inflammatory Biologics Players by Revenue (2016-2021)
6.3 Japan Anti-inflammatory Biologics Historic Market Review by Type (2016-2021)
6.3.1 Japan Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
6.3.2 Japan Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
6.3.3 Japan Anti-inflammatory Biologics Price by Type (2016-2021)
6.4 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Anti-inflammatory Biologics Sales Forecast by Type (2022-2027)
6.4.2 Japan Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027)
6.4.3 Japan Anti-inflammatory Biologics Price Forecast by Type (2022-2027)
6.5 Japan Anti-inflammatory Biologics Historic Market Review by Application (2016-2021)
6.5.1 Japan Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
6.5.2 Japan Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
6.5.3 Japan Anti-inflammatory Biologics Price by Application (2016-2021)
6.6 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Anti-inflammatory Biologics Sales Forecast by Application (2022-2027)
6.6.2 Japan Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027)
6.6.3 Japan Anti-inflammatory Biologics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
7.2 North America Anti-inflammatory Biologics Market Facts & Figures by Country
7.2.1 North America Anti-inflammatory Biologics Sales by Country (2016-2021)
7.2.2 North America Anti-inflammatory Biologics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Region
8.2.1 Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021)
8.2.2 Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
9.2 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
9.2.1 Europe Anti-inflammatory Biologics Sales by Country (2016-2021)
9.2.2 Europe Anti-inflammatory Biologics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
10.2 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
10.2.1 Latin America Anti-inflammatory Biologics Sales by Country (2016-2021)
10.2.2 Latin America Anti-inflammatory Biologics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Description and Business Overview
12.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Anti-inflammatory Biologics Products Offered
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Description and Business Overview
12.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Anti-inflammatory Biologics Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Amgen Inc
12.3.1 Amgen Inc Corporation Information
12.3.2 Amgen Inc Description and Business Overview
12.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen Inc Anti-inflammatory Biologics Products Offered
12.3.5 Amgen Inc Recent Development
12.4 AstraZeneca PLC
12.4.1 AstraZeneca PLC Corporation Information
12.4.2 AstraZeneca PLC Description and Business Overview
12.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products Offered
12.4.5 AstraZeneca PLC Recent Development
12.5 Pfizer, Inc
12.5.1 Pfizer, Inc Corporation Information
12.5.2 Pfizer, Inc Description and Business Overview
12.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer, Inc Anti-inflammatory Biologics Products Offered
12.5.5 Pfizer, Inc Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Anti-inflammatory Biologics Products Offered
12.6.5 Novartis Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Description and Business Overview
12.7.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Roche Anti-inflammatory Biologics Products Offered
12.7.5 Roche Recent Development
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
12.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
12.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products Offered
12.8.5 Sun Pharmaceutical Industries Ltd Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Anti-inflammatory Biologics Products Offered
12.9.5 Sanofi Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Corporation Information
12.10.2 GlaxoSmithKline Description and Business Overview
12.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products Offered
12.10.5 GlaxoSmithKline Recent Development
12.11 AbbVie
12.11.1 AbbVie Corporation Information
12.11.2 AbbVie Description and Business Overview
12.11.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AbbVie Anti-inflammatory Biologics Products Offered
12.11.5 AbbVie Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anti-inflammatory Biologics Industry Trends
13.2 Anti-inflammatory Biologics Market Drivers
13.3 Anti-inflammatory Biologics Market Challenges
13.4 Anti-inflammatory Biologics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-inflammatory Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Anti-inflammatory Biologics Market Insights, Forecast to 2027
List of TablesTable 1. Global Anti-inflammatory Biologics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Synthetic Type
Table 3. Major Manufacturers of Biological Type
Table 4. Global Anti-inflammatory Biologics Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 5. Global Anti-inflammatory Biologics Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Anti-inflammatory Biologics Sales by Regions (2016-2021) & (K MT)
Table 7. Global Anti-inflammatory Biologics Sales Market Share by Regions (2016-2021)
Table 8. Global Anti-inflammatory Biologics Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027) & (K MT)
Table 10. Global Anti-inflammatory Biologics Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Anti-inflammatory Biologics Sales by Manufacturers (2016-2021) (K MT)
Table 14. Global Anti-inflammatory Biologics Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Anti-inflammatory Biologics Manufacturers by Revenue (US$ Million) in 2020
Table 16. Anti-inflammatory Biologics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021)
Table 18. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2020)
Table 20. Key Manufacturers Anti-inflammatory Biologics Price (2016-2021) (USD/MT)
Table 21. Anti-inflammatory Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti-inflammatory Biologics Product Type
Table 23. Date of International Manufacturers Enter into Anti-inflammatory Biologics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Biologics Sales by Type (2016-2021) (K MT)
Table 26. Global Anti-inflammatory Biologics Sales Share by Type (2016-2021)
Table 27. Global Anti-inflammatory Biologics Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Anti-inflammatory Biologics Revenue Share by Type (2016-2021)
Table 29. Anti-inflammatory Biologics Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 30. Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027) & (K MT)
Table 31. Global Anti-inflammatory Biologics Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Anti-inflammatory Biologics Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Anti-inflammatory Biologics Sales by Application (2016-2021) (K MT)
Table 36. Global Anti-inflammatory Biologics Sales Share by Application (2016-2021)
Table 37. Global Anti-inflammatory Biologics Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Anti-inflammatory Biologics Revenue Share by Application (2016-2021)
Table 39. Anti-inflammatory Biologics Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 40. Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027) & (K MT)
Table 41. Global Anti-inflammatory Biologics Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 45. Japan Anti-inflammatory Biologics Sales (K MT) of Key Companies (2016-2021)
Table 46. Japan Anti-inflammatory Biologics Sales Share by Company (2016-2021)
Table 47. Japan Anti-inflammatory Biologics Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Anti-inflammatory Biologics Revenue Share by Company (2016-2021)
Table 49. Japan Anti-inflammatory Biologics Sales (K MT) by Type (2016-2021)
Table 50. Japan Anti-inflammatory Biologics Sales Share by Type (2016-2021)
Table 51. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Anti-inflammatory Biologics Price (USD/MT) by Type (2016-2021)
Table 53. Japan Anti-inflammatory Biologics Sales (K MT) by Type (2022-2027)
Table 54. Japan Anti-inflammatory Biologics Sales Share by Type (2022-2027)
Table 55. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Anti-inflammatory Biologics Revenue Share by Type (2022-2027)
Table 57. Japan Anti-inflammatory Biologics Price (USD/MT) by Type (2022-2027)
Table 58. Japan Anti-inflammatory Biologics Sales (K MT) by Application (2016-2021)
Table 59. Japan Anti-inflammatory Biologics Sales Share by Application (2016-2021)
Table 60. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Anti-inflammatory Biologics Price (USD/MT) by Application (2016-2021)
Table 62. Japan Anti-inflammatory Biologics Sales (K MT) by Application (2022-2027)
Table 63. Japan Anti-inflammatory Biologics Sales Share by Application (2022-2027)
Table 64. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Anti-inflammatory Biologics Revenue Share by Application (2022-2027)
Table 66. Japan Anti-inflammatory Biologics Price (USD/MT) by Application (2022-2027)
Table 67. North America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 68. North America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 69. North America Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021) & (K MT)
Table 72. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021)
Table 75. Europe Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 76. Europe Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 77. Europe Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 79. Latin America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 80. Latin America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 84. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 87. AbbVie Corporation Information
Table 88. AbbVie Description and Business Overview
Table 89. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. AbbVie Anti-inflammatory Biologics Product
Table 91. AbbVie Recent Development
Table 92. Johnson & Johnson Corporation Information
Table 93. Johnson & Johnson Description and Business Overview
Table 94. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Recent Development
Table 97. Amgen Inc Corporation Information
Table 98. Amgen Inc Description and Business Overview
Table 99. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Amgen Inc Product
Table 101. Amgen Inc Recent Development
Table 102. AstraZeneca PLC Corporation Information
Table 103. AstraZeneca PLC Description and Business Overview
Table 104. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. AstraZeneca PLC Product
Table 106. AstraZeneca PLC Recent Development
Table 107. Pfizer, Inc Corporation Information
Table 108. Pfizer, Inc Description and Business Overview
Table 109. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Pfizer, Inc Product
Table 111. Pfizer, Inc Recent Development
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Business Overview
Table 114. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Novartis Product
Table 116. Novartis Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Business Overview
Table 119. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Roche Product
Table 121. Roche Recent Development
Table 122. Sun Pharmaceutical Industries Ltd Corporation Information
Table 123. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 124. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Sun Pharmaceutical Industries Ltd Product
Table 126. Sun Pharmaceutical Industries Ltd Recent Development
Table 127. Sanofi Corporation Information
Table 128. Sanofi Description and Business Overview
Table 129. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. Sanofi Product
Table 131. Sanofi Recent Development
Table 132. GlaxoSmithKline Corporation Information
Table 133. GlaxoSmithKline Description and Business Overview
Table 134. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. GlaxoSmithKline Product
Table 136. GlaxoSmithKline Recent Development
Table 137. Anti-inflammatory Biologics Market Trends
Table 138. Anti-inflammatory Biologics Market Drivers
Table 139. Anti-inflammatory Biologics Market Challenges
Table 140. Anti-inflammatory Biologics Market Restraints
Table 141. Anti-inflammatory Biologics Customers List
Table 142. Anti-inflammatory Biologics Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Biologics Product Picture
Figure 2. Global Anti-inflammatory Biologics Sales Market Share by Type in 2020 & 2027
Figure 3. Synthetic Type Product Picture
Figure 4. Biological Type Product Picture
Figure 5. Global Anti-inflammatory Biologics Sales Market Share by Application in 2020 & 2027
Figure 6. Arthritis
Figure 7. Respiratory Diseases
Figure 8. Dermatology
Figure 9. Gastroenterology
Figure 10. Others
Figure 11. Anti-inflammatory Biologics Report Years Considered
Figure 12. Global Anti-inflammatory Biologics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-inflammatory Biologics Market Size 2016-2027 (US$ Million)
Figure 14. Global Anti-inflammatory Biologics Sales 2016-2027 (K MT)
Figure 15. Global Anti-inflammatory Biologics Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
Figure 17. Global Anti-inflammatory Biologics Sales Market Share by Region in 2020
Figure 18. Global Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021)
Figure 19. Global Anti-inflammatory Biologics Revenue Market Share by Region in 2020
Figure 20. Global Anti-inflammatory Biologics Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Biologics Revenue in 2020
Figure 22. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
Figure 24. Global Anti-inflammatory Biologics Sales Market Share by Type in 2020
Figure 25. Global Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
Figure 26. Global Anti-inflammatory Biologics Revenue Market Share by Type in 2020
Figure 27. Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
Figure 28. Global Anti-inflammatory Biologics Sales Market Share by Application in 2020
Figure 29. Global Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
Figure 30. Global Anti-inflammatory Biologics Revenue Market Share by Application in 2020
Figure 31. Japan Anti-inflammatory Biologics Sales Growth Rate 2016-2027 (K MT)
Figure 32. Japan Anti-inflammatory Biologics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Anti-inflammatory Biologics Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue in Anti-inflammatory Biologics in 2020
Figure 35. Japan Anti-inflammatory Biologics Revenue Share by Type (2016-2021)
Figure 36. Japan Anti-inflammatory Biologics Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Anti-inflammatory Biologics Revenue Share by Application (2016-2021)
Figure 38. Japan Anti-inflammatory Biologics Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT)
Figure 40. North America Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Anti-inflammatory Biologics Sales Market Share by Country in 2020
Figure 42. North America Anti-inflammatory Biologics Revenue Market Share by Country in 2020
Figure 43. U.S. Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 44. U.S. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 46. Canada Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT)
Figure 48. Europe Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Anti-inflammatory Biologics Sales Market Share by Country in 2020
Figure 50. Europe Anti-inflammatory Biologics Revenue Market Share by Country in 2020
Figure 51. Germany Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 52. Germany Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 54. France Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 56. U.K. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 58. Italy Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 60. Russia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT)
Figure 62. Asia Pacific Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region in 2020
Figure 64. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region in 2020
Figure 65. China Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 66. China Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 68. Japan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 70. South Korea Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 72. India Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 74. Australia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 76. Taiwan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 78. Indonesia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 80. Thailand Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 82. Malaysia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 84. Philippines Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 86. Vietnam Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT)
Figure 88. Latin America Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Anti-inflammatory Biologics Sales Market Share by Country in 2020
Figure 90. Latin America Anti-inflammatory Biologics Revenue Market Share by Country in 2020
Figure 91. Mexico Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 92. Mexico Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 94. Brazil Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 96. Argentina Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT)
Figure 98. Middle East and Africa Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country in 2020
Figure 101. Turkey Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 102. Turkey Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 104. Saudi Arabia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT)
Figure 106. U.A.E Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Anti-inflammatory Biologics Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Keyplayers in Global and Japan Anti-inflammatory Biologics Market Insights, Forecast to 2027
AbbVieJohnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline